Risperidone Kit
Product Images NDC 70121-2628

Product Visual Gallery

This gallery contains 68 technical images submitted to the FDA as part of the official labeling for Risperidone (NDC 70121-2628). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 1)

This text provides a short description of a product or device that is designed for single-use. It likely refers to a type of medical or pharmaceutical device that is meant to be used only once and then disposed of.*

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 10)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 11)

Description: This text provides instructions for removing the vial adapter from a sterile blister when ready to take off the white cap from a prefilled syringe. It is a crucial step in handling medical equipment effectively.*

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 12)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 13)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 14)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 15)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 16)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 17)

This text provides instructions for maintaining pressure on the plunger rod of a vial to prevent potential spillage or leakage.*

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 18)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 19)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 2)

This is an image showing a luer opening with a spike tip and a skirt. The luer opening allows for connecting various medical devices or instruments securely. The spike tip is designed for easy piercing or insertion, while the skirt provides additional stability or support.*

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 20)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 21)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 22)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 23)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 24)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 25)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 26)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 27)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 28)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 29)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 3)

This text appears to be a list of different items or components. It includes "Plunger", "White", "rod collar", "B =", "Diluent". The details are a bit unclear, but it seems to be a description of various parts or objects, possibly related to a tool or machine.*

FDA Label Image

051 (Risperidone For Extended Release Injectable Suspen 30)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 31)

This text states "SINGLE-DOSE DEVICE" which refers to a type of product or device that is designed to be used only for a single dose or application. These devices are often used in the medical and pharmaceutical industry for dispensing medications or treatments in a single-use format.*

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 32)

This is a description of a luer opening with a spike tip and a skirt. It is likely referring to a medical device or apparatus with these features for connecting different components or parts.*

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 33)

This appears to be a list of different components or parts, possibly related to a mechanical device or instrument. It seems to include items such as a plunger, a white rod collar, and a diluent. Each item is listed separately with a brief description. It is likely used for reference or inventory purposes.*

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 34)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 35)

This is a description of a transparent 2-inch needle safety device designed for protecting the needle when not in use. The device is specifically mentioned for gluteal use.*

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 36)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 37)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 38)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 39)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 4)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 40)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 41)

This text provides instructions for using a vial adapter by advising to remove it from the sterile blister only when ready to remove the white cap from the prefilled syringe. It is important to follow these steps to ensure proper usage of the medical device.*

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 42)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 43)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 44)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 45)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 46)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 47)

This is not available.*

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 48)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 49)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 5)

This is a description of a gluteal 2-inch needle safety device with a transparent needle protector. *

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 50)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 51)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 52)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 53)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 54)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 55)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 56)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 57)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 58)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 59)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 6)

FDA Label Image

125 (Risperidone For Extended Release Injectable Suspen 60)

This text appears to be a description of a pharmaceutical product labeled as "Risperidone for Extended-Release Injectable Suspension." The medication is indicated for intramuscular injection in the deltoid or gluteal muscles. Each vial contains 12.5 mg of risperidone and is for single-dose use only. The product is manufactured by Amneal Pharmaceuticals LLC and should be used according to the instructions provided on the label. Additionally, it includes information on the lot number, expiration date, and the manufacturer's location.*

FDA Label Image

1250 (Risperidone For Extended Release Injectable Suspen 61)

The text provides information about a prescription medication called risperidone for Extended-Release Injectable Suspension in a single-dose pack. It includes details such as the NDC number, dosage, and components of the pack like pre-filled syringes and needles. The text also mentions storage instructions, administration guidelines, and contact information for further inquiries. This medication is intended for intramuscular injection only under the supervision of a healthcare professional.*

FDA Label Image

25 (Risperidone For Extended Release Injectable Suspen 62)

This text provides information about a medication identified by its NDC code (70121-1351-1) called risperidone for Extended-Release Injectable Suspension. It comes in single-dose vials with a concentration of 25 mg/vial and is meant for intramuscular injections in the deltoid or gluteal area. The prescription medication is for use in a specific way and requires a specific administration technique. The text includes markings for a Varnish Free Area and specific Peel Area instructions, along with codes related to the medicine. Additionally, there are symbols and characters throughout the text indicating essential instructions for use.*

FDA Label Image

250 (Risperidone For Extended Release Injectable Suspen 63)

FDA Label Image

375 (Risperidone For Extended Release Injectable Suspen 64)

FDA Label Image

3750 (Risperidone For Extended Release Injectable Suspen 65)

This is information regarding a prescription drug labeled as "risperidone for Extended-Release Injectable Suspension" in a 37.5 mg/vial dosage. It is intended for intramuscular injection in the deltoid or gluteal muscles and should only be administered by a healthcare professional. The package should be stored in the refrigerator. The product contains microspheres of risperidone microencapsulated in polylactic-co-glycolic acid. For more details, refer to the instructions provided on the packaging. Instructions to store the package in a refrigerator are mentioned with additional resources for information available on the manufacturer's website or through a provided phone number.*

FDA Label Image

500 (Risperidone For Extended Release Injectable Suspen 66)

This text is related to a pharmaceutical product called Risperidone for Extended-Release Injectable Suspension. It is intended for single-dose use only and for intramuscular injection in the deltoid or gluteal region. The product is microencapsulated and manufactured in a facility with certain specifications like a varnish-free area perforation. The document includes the drug's NDC (National Drug Code) number, handling instructions, and code details for identification.*

FDA Label Image

505 (Risperidone For Extended Release Injectable Suspen 67)

The text provides information about the administration of Risperidone for Extended-Release Injectable Suspension in single-dose packs. The medication is intended for intramuscular injections in the deltoid or gluteal regions. The pack includes different components like a 50mg vial of extended-release microspheres for injection, pre-filled syringe with 2 mL of solvent, and a vial adapter. It emphasizes that injections should be given by healthcare professionals and provides storage instructions for the medication. It also mentions the safety needles included in the pack and not to substitute any components. Additionally, it provides contact information for Amneal Pharmaceuticals LLC for further information.*

FDA Label Image

101 (Risperidone For Extended Release Injectable Suspen 68)

This text contains information about an injectable suspension medication that is for single-dose use only. It includes details such as the lot number, expiration date, manufacturing license number, and instructions for intramuscular injection in either the deltoid or gluteal area. The medication is labeled as an extended-release formulation. The product is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ and manufactured in India.*

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 7)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 8)

FDA Label Image

1 (Risperidone For Extended Release Injectable Suspen 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.